tradingkey.logo

Bio-Techne Corp

TECH
View Detailed Chart
62.020USD
-1.920-3.00%
Close 10/29, 16:00ETQuotes delayed by 15 min
9.61BMarket Cap
131.01P/E TTM

Bio-Techne Corp

62.020
-1.920-3.00%
Intraday
1m
30m
1h
D
W
M
D

Today

-3.00%

5 Days

-2.77%

1 Month

+18.74%

6 Months

+22.81%

Year to Date

-13.90%

1 Year

-12.33%

View Detailed Chart

TradingKey Stock Score of Bio-Techne Corp

Currency: USD Updated: 2025-10-29

Key Insights

The company's fundamentals are relatively very healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite an average stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Bio-Techne Corp's Score

Industry at a Glance

Industry Ranking
44 / 407
Overall Ranking
133 / 4623
Industry
Biotechnology & Medical Research

Support & Resistance

No Data

Score Analysis

Current score
Previous score

Analyst Rating

Based on 17 analysts
Buy
Current Rating
66.556
Target Price
+4.09%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Bio-Techne Corp Highlights

StrengthsRisks
Bio-Techne Corporation is a global life sciences company providing tools and bioactive reagents for the research and clinical diagnostic communities. The Company's products assist scientific investigations into biological processes and the nature and progress of specific diseases. The Company, in partnership with Wilson Wolf, is creating products such as media and cytokines that are specifically tailored to G-Rex Bioreactors. Its segments include Protein Sciences and Diagnostics and Genomics. The Protein Sciences segment is a developer and manufacturer of biological reagents used in all aspects of life science research, diagnostics and cell and gene therapy. This segment also includes proteomic analytical tools, both manual and automated. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for the regulated diagnostics market, exosome-based molecular diagnostic assays, and tissue biopsy analysis.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 68.69%.
Stable Dividend
The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 68.69%.
Overvalued
The company’s latest PE is 133.17, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 161.69M shares, decreasing 4.59% quarter-over-quarter.
Held by Wallace Weitz
Star Investor Wallace Weitz holds 802.15K shares of this stock.

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Bio-Techne Corp Info

Bio-Techne Corporation is a global life sciences company providing tools and bioactive reagents for the research and clinical diagnostic communities. The Company's products assist scientific investigations into biological processes and the nature and progress of specific diseases. The Company, in partnership with Wilson Wolf, is creating products such as media and cytokines that are specifically tailored to G-Rex Bioreactors. Its segments include Protein Sciences and Diagnostics and Genomics. The Protein Sciences segment is a developer and manufacturer of biological reagents used in all aspects of life science research, diagnostics and cell and gene therapy. This segment also includes proteomic analytical tools, both manual and automated. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for the regulated diagnostics market, exosome-based molecular diagnostic assays, and tissue biopsy analysis.
Ticker SymbolTECH
CompanyBio-Techne Corp
CEOMr. Kim Kelderman
Websitehttps://www.bio-techne.com/
KeyAI